going well. 1020 explained very well. 1040 - talking about how the drug works like a cast for the heart (regulated as a device). Pilot study went well with no adverse events. Partner - Ikaria is based in NJ. Now discussing the rest of the pipeline.
That would be a reasonable assumption. He also said BL-1040 might eventually be in a billion dollar space. There are now 21 million shares out in terms of ADS equivalents, that was in the presentation, but of course cash position is increased. Everybody interested can listen to the presentation again. He also said they looked at dozens of projects and only pursued only those that might prove fruitful. The other pipe line projects sounded interesting and are moving forward.